Literature DB >> 12130457

Application of oral contrast media in coregistered positron emission tomography-CT.

Elena V Dizendorf1, Valerie Treyer, Gustav K Von Schulthess, Thomas F Hany.   

Abstract

OBJECTIVE: Coregistration of positron emission tomography (PET) and CT images results in significantly improved localization of abnormal FDG uptake compared with PET images alone. For delineation of intestinal structures, application of oral contrast media is a standard procedure in CT. The influence of oral contrast agents in PET imaging using CT data for attenuation correction was evaluated in a comparative study on an in-line PET-CT system. SUBJECTS AND METHODS: Sixty patients referred for PET-CT were evaluated in two groups. One group of 30 patients received oral Gastrografin 45 min before data acquisition. The second group received no contrast medium. PET images were reconstructed, using CT data for attenuation correction. Image analysis was performed by two reviewers in consensus, using a 4-point scale comparing FDG-uptake in the gastrointestinal tract in PET images of both groups. Furthermore, correlation of FDG uptake and localization of contrast media in the intestinal tract in CT images were determined.
RESULTS: No significant difference in FDG uptake in PET images in all regions of the gastrointestinal tract except the ascending colon was seen in both groups. No correlation was found in the location of increased FDG uptake and contrast media in the CT images.
CONCLUSION: An oral contrast agent can be used for coregistered PET-CT without the introduction of artifacts in PET.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12130457     DOI: 10.2214/ajr.179.2.1790477

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  20 in total

Review 1.  PET/CT: a new imaging technology in nuclear medicine.

Authors:  Heiko Schöder; Yusuf E Erdi; Steven M Larson; Henry W D Yeung
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-05       Impact factor: 9.236

2.  Calcified Lymph Nodes Causing Clinically Relevant Attenuation Correction Artifacts on PET/CT Imaging.

Authors:  Amar Mehta; Ajeet Mehta; Charles Laymon; Todd M Blodgett
Journal:  J Radiol Case Rep       Date:  2010-02-01

3.  Assessment of errors caused by X-ray scatter and use of contrast medium when using CT-based attenuation correction in PET.

Authors:  Mohammad Reza Ay; Habib Zaidi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-19       Impact factor: 9.236

4.  Oral contrast medium in PET/CT: should you or shouldn't you?

Authors:  Ashley M Groves; Irfan Kayani; John C Dickson; Caroline Townsend; Ian Croasdale; Rizwan Syed; Nagesh Nagabushan; Sharon F Hain; Peter J Ell; Jamshed B Bomanji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-06-04       Impact factor: 9.236

5.  The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.

Authors:  Ronald Boellaard; Wim J G Oyen; Corneline J Hoekstra; Otto S Hoekstra; Eric P Visser; Antoon T Willemsen; Bertjan Arends; Fred J Verzijlbergen; Josee Zijlstra; Anne M Paans; Emile F I Comans; Jan Pruim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-15       Impact factor: 9.236

6.  Correction of oral contrast artifacts in CT-based attenuation correction of PET images using an automated segmentation algorithm.

Authors:  Alireza Ahmadian; Mohammad R Ay; Javad H Bidgoli; Saeed Sarkar; Habib Zaidi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-17       Impact factor: 9.236

7.  Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness.

Authors:  Stefan Heinrich; Gerhard W Goerres; Markus Schäfer; Markus Sagmeister; Peter Bauerfeind; Bernhard C Pestalozzi; Thomas F Hany; Gustav K von Schulthess; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

8.  PET/CT artifacts.

Authors:  Todd M Blodgett; Ajeet S Mehta; Amar S Mehta; Charles M Laymon; Jonathan Carney; David W Townsend
Journal:  Clin Imaging       Date:  2011 Jan-Feb       Impact factor: 1.605

9.  The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate.

Authors:  G W Goerres; R Stupp; G Barghouth; T F Hany; B Pestalozzi; E Dizendorf; P Schnyder; F Luthi; G K von Schulthess; S Leyvraz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-04       Impact factor: 9.236

10.  Quality assurance of positron emission tomography/computed tomography for radiation therapy.

Authors:  Lei Xing
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.